日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Next-generation anti-DLL3 radiopharmaceuticals targeting high-grade neuroendocrine lung and prostate cancers

针对高级别神经内分泌肺癌和前列腺癌的新一代抗DLL3放射性药物

Tendler, Salomon; De Gregorio, Roberto; Balderes, Paul; Michel, Alexa L; Hoang, Tran T; Bauer, David; Tully, Kathryn M; Korsen, Joshua A; Lorenz, Ivo C; Khan, Abdul G; Carter, Lukas; Vergnolle, Olivia; Lebedeva, Irina V; Nyakatura, Elisabeth K; Bodei, Lisa; Morris, Michael J; Poirier, John T; Rudin, Charles M; Lewis, Jason S

Precision imaging and evolving therapies in paragangliomas and pheochromocytomas: from molecular diagnostics to imaging-guided management

副神经节瘤和嗜铬细胞瘤的精准影像学及不断发展的治疗方法:从分子诊断到影像引导治疗

Choucair, Aurelie; Zdunek, Anna; Liao, Matthew; Bodei, Lisa; Deandreis, Desiree; Das, Jeeban; Barbe, Remy; Bergsland, Emily; Geyer, Susan; Bidault, Francois; Garcia, Gabriel; Yeh, Randy; Balleyguier, Corinne; Lassau, Nathalie; Dercle, Laurent; Ammari, Samy

When AI takes the wheel: AI-defined vehicles principles and pitfalls

当人工智能掌舵:人工智能定义的车辆的原则和陷阱

De Vincenzi, Marco; Bodei, Chiara; Matteucci, Ilaria

Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET)

非功能性晚期胃肠胰神经内分泌肿瘤管理临床实践指南:采用 GRADE 方法进行证据评估和建议,由意大利肿瘤内科学会 (AIOM) 与意大利神经内分泌肿瘤协会 (ITANET) 合作制定。

Spada, F; Gelsomino, F; Rinzivillo, M; Cinquini, M; Fittipaldo, V A; Tralongo, A; Moschetti, I; Albertelli, M; Ambrosini, V; Amoroso, V; Antonuzzo, L; Badalamenti, G; Bajetta, E; Baldari, S; Barberis, M; Berruti, A; Bertani, E; Bonomo, G; Bodei, L; Buzzoni, R; Brizzi, M P; Campana, D; Capurso, G; Casadei, R; Castellano, M; Cingarlini, S; Cives, M; Colao, A M; Coppa, J; Cremonini, N; Davì, M V; De Angelis, C G; de Braud, F; De Robertis, R; Faggiano, A; Falconi, M; Fassan, M; Ferolla, P; Ferone, D; Filice, A; Fiore, F; Funicelli, L; Granata, V; Giuffrida, D; Grana, C M; Grimaldi, F; Ibrahim, T; La Salvia, A; Laghi, A; Luppi, G; Maccauro, M; Marconcini, R; Massironi, S; Mazzaferro, V; Merola, E; Milione, M; Modica, R; Ortolani, S; Papotti, M G; Partelli, S; Pelosi, G; Pusceddu, S; Ramundo, V; Ravizza, D; Razzore, P; Reimondo, G; Ricci, C; Rindi, G; Rizzo, F M; Rossi, R E; Tafuto, S; Tiberio, G A M; Versari, A; Vigorito, R; Zatelli, M C; Di Maio, M; Perrone, F; Cinieri, S; Panzuto, F; Fazio, N

Loss of DAXX/ATRX Protein Expression Results in Ischemia Resistance and Radiation Sensitivity in Pancreatic Neuroendocrine Tumor Cells and Is Associated with Improved Response to Trans-Arterial Radioembolization.

DAXX/ATRX 蛋白表达的丧失导致胰腺神经内分泌肿瘤细胞的缺血抵抗和放射敏感性,并且与经动脉放射栓塞治疗反应的改善有关

Puzzuoli Jessica C, Solivio Caleb, Yuan Gavin, Rizzo Anthony J, Graham Mindy K, Shenker Larissa, Vista Will, Gil Adam, Singh Himanshu, Alexander Erica, Gonzalez-Aguirre Adrian, Latzman Jonathan, Petre E Nadia, Yarmohammadi Hooman, Erinjeri Joseph P, Covey Anne, Chan Eric, Russell James, Bodei Lisa, Raj Nitya, Reidy-Lagunes Diane, Heaphy Christopher M, Ziv Etay

Symptomatic Prostate-Specific Membrane Antigen PET-Positive Radionecrosis After Multimodality Brain Metastasis-Directed Treatment Including [(177)Lu]Lu-PSMA-617

接受包括[(177)Lu]Lu-PSMA-617在内的多模式脑转移瘤靶向治疗后出现症状性前列腺特异性膜抗原PET阳性放射性坏死

Imber, Brandon S; Yu, Kenny Kwok Hei; Abida, Wassim; Pike, Luke R G; Grkovski, Milan; Kaley, Thomas J; Morris, Michael J; Bodei, Lisa; Nosov, Anton; Dunphy, Mark P S; Schöder, Heiko; Fox, Josef J; Rosenblum, Marc; Bale, Tejus; Krebs, Simone

Delta-like ligand 3 expression and functional imaging in gastroenteropancreatic neuroendocrine neoplasms

Delta样配体3在胃肠胰神经内分泌肿瘤中的表达及功能成像

Thummalapalli, Rohit; Tendler, Salomon; Chou, Joanne F; Tarcan, Zeynep C; Porfido, Courtney; Willner, Jonathan; Linkov, Irina; Bhanot, Umesh; Cooper, Alissa J; Xu, Jierui; Harding, James J; Rekhtman, Natasha; Tang, Laura H; Rudin, Charles M; Janjigian, Yelena Y; Schöder, Heiko; Porier, John T; Shia, Jinru; Basturk, Olca; Reidy-Lagunes, Diane; Capanu, Marinela; Lewis, Jason S; Bodei, Lisa; Dunphy, Mark P; Raj, Nitya

Extravasation Frequency of [(177)Lu]Lu-DOTATATE: Insights and Implications Derived from 1,314 Cycles of Treated Patients-A Single-Site Analysis

[(177)Lu]Lu-DOTATATE 的外渗频率:来自 1314 个治疗周期患者的单中心分析的见解和意义

Kayal, Gunjan; Augensen, Finn; Bodei, Lisa; Chu, Bae; Marquis, Harry; Carter, Lukas M; Humm, John; Kesner, Adam L

Lesion Absorbed Dose-Response Relationship in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [(177)Lu]Lu-PSMA-617 Radiopharmaceutical Therapy

转移性去势抵抗性前列腺癌患者接受[(177)Lu]Lu-PSMA-617放射性药物治疗后病灶吸收剂量反应关系

Grkovski, Milan; Krebs, Simone S; O'Donoghue, Joseph A; Kuten, Jonathan; Mauguen, Audrey; Shobeiri, Parnian; Lafontaine, Daniel; Thor, Maria; Augensen, Finn; Fox, Josef J; Pandit-Taskar, Neeta; Dunphy, Mark P; Bodei, Lisa; Humm, John L; Schöder, Heiko

Differential Clearance of [(177)Lu]Lu-PSMA-617 from Metastatic Prostate Cancer Lesions and Normal Tissues creates a Window for Safe Application of DNA Repair Inhibitors

[(177)Lu]Lu-PSMA-617 从转移性前列腺癌病灶和正常组织中的清除差异,为安全应用 DNA 修复抑制剂创造了窗口期。

Russell, James; Grkovski, Milan; O'Donoghue, Joseph A; Franca-Velo, Alexandre; Krebs, Simone; Bodei, Lisa; Schöder, Heiko; Humm, John L